Download PDF
Psychiatr Prax 2006; 33(5): 211-217
DOI: 10.1055/s-2005-866996
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Prädiktive Diagnostik bei Chorea Huntington: Psychotherapeutische Aspekte der Beratung von Risikopersonen

Predictive Diagnostics in Chorea Huntington: Psychotherapeutic Implications for CounsellingElke  Richartz-Salzburger1 , Ulrike  Mau-Holzmann2 , Klaus  Joachim  Schott1 , Gerhard  Buchkremer1
  • 1Universitätsklinik für Psychiatrie und Psychotherapie, Tübingen
  • 2Institut für Humangenetik, Abteilung Medizinische Genetik, Tübingen
Further Information

Publication History

Publication Date:
27 June 2006 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Der Fortschritt der molekulargenetischen Forschung ermöglicht zunehmend die prädiktive Diagnostik erblich bedingter Erkrankungen. Vor dem Hintergrund der Literatur werden die komplexen psychischen Aspekte prädiktiver Diagnostik ausgeführt und bestehende Beratungsansätze zusammengefasst. Trotz umfangreicher Studien sind die psychischen Reaktionen im Einzelfall schwer einzuschätzen. Wesentlich erscheint, genügend Zeit vor der Untersuchung zu gewinnen, um auch unbewusste Einflüsse auf Motivation und Bewältigungsstrategien berücksichtigen zu können. Auch nach der Ergebnismitteilung sollte den Betroffenen eine stützende Beratung angeboten werden.

Abstract

The progress in molecular genetic research leads to an increased availability of predictive diagnosis of inherited diseases. However, the prediction of an incurable illness is inevitably related with severe psychic conflicts. Based on the relevant literature, the psychological implications of predictive diagnostics are outlined, and counselling strategies for persons vulnerable for an inherited disease are summarized. In spite of numerous studies with persons at risk the prediction of the individual reaction remains rather difficult. Unconscious expectations play an essential, but underestimated role for the test motivation and coping strategies. Relieving the pressure of time supposed by most of the risk persons seems necessary to allow a deeper understanding of motivation and development of sound coping strategies. After disclosure of the test result, an ongoing counselling should be offered to all family members.

Literatur

  • 1 Zühlke C, Thies U. Chorea Huntington: Molekulargenetische Grundlagen, Mutationsnachweis und prädiktive Diagnostik.  Nervenarzt. 1996;  67 25-35
    PubMedSearch in Google Scholar
  • 2 Harper P S. Huntington Disease. London; WB Saunders Co 1996
    Search in Google Scholar
  • 3 Gusella J F, Wexler N S, Conneally P M. et al . A polymorphic DNA marker genetically linked to Huntington's disease.  Nature. 1983;  306 234-238
    CrossrefPubMedSearch in Google Scholar
  • 4 Huntingtons's Disease Collaborative Research Group . A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington' disease chromosomes.  Cell. 1993;  72 971-983
    CrossrefPubMedSearch in Google Scholar
  • 5 Tibben A, Niermeijer M F, Roos R AC. et al . Understanding the low uptake of presymptomatic DNA-testing for Huntington's disease.  Lancet. 1992;  340 1416
    PubMedSearch in Google Scholar
  • 6 Laccone F, Engel U, Holonski-Feder E. et al . DNA analysis of Huntington's disease. Five years of experience in Germany, Austria, and Switzerland.  Neurology. 1999;  53 801-806
    CrossrefPubMedSearch in Google Scholar
  • 7 Hayden M R. Predictive testing for Huntington's disease: the calm after the storm.  Lancet. 2000;  356 1944-1945
    CrossrefPubMedSearch in Google Scholar
  • 8 Creighton S, Almquist E W, MacGregor D. et al . Predictive, prenatal and diagnostic genetic testing for Huntingtons' disease: the experience in Canada from 1987 to 2000.  Clin Genet. 2003;  63 462-475
    CrossrefPubMedSearch in Google Scholar
  • 9 Harper P S, Lim C, Craufurd D. Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium.  J Med Genet. 2000;  37 567-571
    CrossrefPubMedSearch in Google Scholar
  • 10 Kessler S. Predictive Testing for Huntington's Disease: A Psychologist's View.  Am J MedGen. 1994;  54 161-166
    CrossrefPubMedSearch in Google Scholar
  • 11 Kreuz F R. Attitudes of german persons at risk for Huntington's Disease toward predictive and prenatal testing.  Genetic counselling. 1996;  7 303-311
    PubMedSearch in Google Scholar
  • 12 Evers-Kiebooms G, Swerts A, Cassiman J J, Berghe H Van den. The motivation of at risk individuals and their partners in deciding for or against predictive testing for Huntington's disease.  Clin Genet. 1989;  54 174-184
    PubMedSearch in Google Scholar
  • 13 Tibben A. Presymptomatic testing for Huntington's disease.  Am J Med Genet. 1993;  48 103-111
    CrossrefPubMedSearch in Google Scholar
  • 14 Codori A M, Hanson R, Brandt J. Self-selection in predictive testing for Huntington's disease.  Am J Med Genet. 1994;  54 167-173
    CrossrefPubMedSearch in Google Scholar
  • 15 Lazarus R S, Folkman S. Stress, appraisal, and coping. New York; Springer 1994
    Search in Google Scholar
  • 16 Copley T T, Wiggins S, Dufrasne S. et al . Are we all of one mind? Clinicians' and patients' opinions regarding the development of a service protocol for predictive testing for Huntington's disease.  Am J Med Genet. 1995;  58 59-69
    CrossrefPubMedSearch in Google Scholar
  • 17 Bloch M, Adam S, Fuller A. et al . Diagnosis of Huntington's disease: A model for the stages of psychological response based on experience of a predictive testing program.  Am J Med Genet. 1993;  47 368-374
    CrossrefPubMedSearch in Google Scholar
  • 18 Quaid K A. Presymptomatic testing for Huntington's disease: The U. S. experience.  Am J Hum Genet. 1993;  51 1063
    PubMedSearch in Google Scholar
  • 19 Codori A M, Brandt J. Psychological costs and benefits of predictive testing for Huntington's disease.  Am J Med Genet. 1994;  54 174-184
    CrossrefPubMedSearch in Google Scholar
  • 20 Tibben A, Frets P G, Kamp J JP Van de. et al . On attitudes and appreciation 6 months after predictive DNA-testing for Huntington's disease in the Dutch program.  Am J Med Genet. 1993;  48 103-111
    CrossrefPubMedSearch in Google Scholar
  • 21 Huggins M, Bloch M, Wiggins S. et al . Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk.  Am J Med Genet. 1992;  42 508-515
    CrossrefPubMedSearch in Google Scholar
  • 22 Sobel K S, Cowan D B. Impact of genetic testing for Huntington disease on the family system.  Am J Med Gen. 2000;  90 49-59
    CrossrefPubMedSearch in Google Scholar
  • 23 Decruyenaere M, Evers-Kiebooms G, Cloostermans T, Boogaerts A, Demyttenaere K, Dom R, Fryns J P. Predictive testing for Huntingon's disease: relationship with partners after testing.  Clin Genet. 2004;  65 24-31
    CrossrefPubMedSearch in Google Scholar
  • 24 Wiggins S, Whyte P, Huggins M. et al . The psychological consequences of predictive testing for Huntingtons's disease.  New Engl J Med. 1992;  327 1401-1405
    PubMedSearch in Google Scholar
  • 25 Hayden M R. Predictive testing in Huntington's disease. Are we ready for widespread community implementation?.  Am J Med Genet. 1991;  40 515-517
    CrossrefPubMedSearch in Google Scholar
  • 26 Lawson K, Wiggins S, Green T. et al . Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.  J Med Genet. 1996;  33 856-862
    PubMedSearch in Google Scholar
  • 27 DudokdeWit A C, Tibben A, Duivenvoorden H J, Niermeijer M F, Passchier J. Distress in individuals facing predictive DNA testing for autosomal dominant late onset disorders: Comparing questionnaire results with in-depth interviews.  Am J Med Genetic. 1998;  75 62-74
    PubMedSearch in Google Scholar
  • 28 Almquist E W, Bloch M, Brinkman R. et al . A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.  Am J Hum Genet. 1999;  64 1293-1304
    CrossrefPubMedSearch in Google Scholar
  • 29 Almquist E W, Brinkman R R, Wiggins S, Hayden R. Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntingtons' disease.  Clin Genet. 2003;  64 300-309
    CrossrefPubMedSearch in Google Scholar
  • 30 Timman R, Roos R, Maat-Kievit A, Tibben A. Adverse effects of predictive testing for Huntington's disease underestimated: long-term effects 7 - 10 years after the test.  Health Psychol. 2004;  23 189-207
    CrossrefPubMedSearch in Google Scholar
  • 31 Evers-Kiebooms G. Predictive testing for Huntington's disease in Belgium.  J Psychosom Obstet Gynecol. 1990;  11 61-72
    PubMedSearch in Google Scholar
  • 32 Decruyenaere M, Evers-Kiebooms G, Boogaerts A. et al . Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.  J Med Genet. 1996;  33 737-743
    PubMedSearch in Google Scholar
  • 33 International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea . Guidelines for the molecular genetics predictive test in Huntington's disease.  Neurology. 1994;  44 1533-1536
    PubMedSearch in Google Scholar
  • 34 Sharpe N F. Informed consent and Huntington's disease: A model for communication.  Am J Med Gen. 1994;  50 236-239
    PubMedSearch in Google Scholar
  • 35 Meincke U, Kosinski C H, Zerres K, Maio G. Psychiatrische und ethische Aspekte genetischer Diagnostik am Beispiel Huntington.  Nervenarzt. 2003;  74 413-419
    CrossrefPubMedSearch in Google Scholar
  • 36 Müller A, Kreuz F R. Copingstrategien für die Huntingtonsche Krankheit.  Neurol Rehabil. 1998;  4 71-75
    PubMedSearch in Google Scholar
  • 37 Laplanche J, Pontalis J-B. Das Vokabular der Psychoanalyse. Frankfurt a. M.; Suhrkamp 1972: 595-598
    Search in Google Scholar
  • 38 Beutel M. Zur Erforschung der Verarbeitung chronischer Krankheit: Konzeptualisierung, Operationalisierung und Adaptivität von Abwehrprozessen am Beispiel der Verleugnung.  Psychother med Psychol. 1985;  35 295-302
    PubMedSearch in Google Scholar
  • 39 Steffens W, Kächele H. Abwehr und Bewältigung - Mechanismen und Strategien. In: Kächele H, Steffens W (Hrsg) Bewältigung und Abwehr. Beiträge zur Psychologie und Psychotherapie schwerer körperlicher Krankheiten. Berlin, Heidelberg; Springer 1988: 1-50
    Search in Google Scholar
  • 40 Richartz E, Frank C. Psychodynamisch orientierte Beratung im Rahmen prädiktiver Diagnostik bei Chorea Huntington.  Psychiat Prax. 2004;  31 255-258
    Thieme ConnectPubMedSearch in Google Scholar
  • 41 Steenstraaten I M Van der, Tibben A, Roos R AC. et al . Predictive testing for Huntington's disease: Nonparticipants compared with participants in the Dutch program.  Am J Hum Genet. 1994;  55 618-625
    PubMedSearch in Google Scholar
  • 42 Meissen G J, Mastromauro C A, Kiely D K. et al . Understanding the decision to take the predictive test for Huntington's disease.  Am J Med Genet. 1991;  39 404-410
    CrossrefPubMedSearch in Google Scholar
  • 43 Binedell J, Soldan J R. Nonparticipation in Huntington's Disease Predictive testing: reasons for caution in interpreting findings.  J of Genetic Counseling. 1997;  6 419-432
    PubMedSearch in Google Scholar
  • 44 Speit D. Erfahrungen mit der psychotherapeutischen Begleitung vor prädiktiver DNA-Diagnostik.  Deutsche Huntington Hilfe. 1993;  93 7-11
    PubMedSearch in Google Scholar
  • 45 Tassicker R J. Psychodynamic theory and counselling in predictive testing for Huntington's disease.  J Genet Couns. 2005;  14 99-107
    PubMedSearch in Google Scholar

Dr. med. Elke Richartz-Salzburger

Universitätsklinik für Psychiatrie und Psychotherapie

72076 Tübingen

Email: elke.richartz@med.uni-tuebingen.de